Predictive Values of EGFR expression for the Fluoropyrimidine Metronomic Maintenance Therapy in Patients with Stage III Colorectal Cancer after Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy
How to cite: Huang, C.; Ma, C.; Chen, Y.; Tsai, H.; Yeh, Y.; Su, W.; Chang, T.; Hsu, W.; Yu, F.; Wang, J. Predictive Values of EGFR expression for the Fluoropyrimidine Metronomic Maintenance Therapy in Patients with Stage III Colorectal Cancer after Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy. Preprints 2019, 2019120246. https://doi.org/10.20944/preprints201912.0246.v1 Huang, C.; Ma, C.; Chen, Y.; Tsai, H.; Yeh, Y.; Su, W.; Chang, T.; Hsu, W.; Yu, F.; Wang, J. Predictive Values of EGFR expression for the Fluoropyrimidine Metronomic Maintenance Therapy in Patients with Stage III Colorectal Cancer after Radical Resection and Adjuvant Oxaliplatin-Based Chemotherapy. Preprints 2019, 2019120246. https://doi.org/10.20944/preprints201912.0246.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)